China
· Delayed Price · Currency is CNY Beijing Tiantan Biological Products Statistics
Total Valuation
Beijing Tiantan Biological Products has a market cap or net worth of CNY 44.73 billion. The enterprise value is 43.17 billion.
| Market Cap | 44.73B |
| Enterprise Value | 43.17B |
Important Dates
The last earnings date was Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 20, 2024 |
Share Statistics
Beijing Tiantan Biological Products has 1.98 billion shares outstanding. The number of shares has increased by 1.32% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.98B |
| Shares Change (YoY) | +1.32% |
| Shares Change (QoQ) | +2.26% |
| Owned by Insiders (%) | 2.80% |
| Owned by Institutions (%) | 18.43% |
| Float | 949.60M |
Valuation Ratios
The trailing PE ratio is 35.46 and the forward PE ratio is 32.53.
| PE Ratio | 35.46 |
| Forward PE | 32.53 |
| PS Ratio | 8.64 |
| PB Ratio | 4.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 165.76 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.60, with an EV/FCF ratio of 159.99.
| EV / Earnings | 33.88 |
| EV / Sales | 8.25 |
| EV / EBITDA | 18.60 |
| EV / EBIT | 21.68 |
| EV / FCF | 159.99 |
Financial Position
The company has a current ratio of 5.51, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.51 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.15 |
| Interest Coverage | 582.11 |
Financial Efficiency
Return on equity (ROE) is 13.14% and return on invested capital (ROIC) is 9.36%.
| Return on Equity (ROE) | 13.14% |
| Return on Assets (ROA) | 8.25% |
| Return on Capital (ROIC) | 9.36% |
| Revenue Per Employee | 1.08M |
| Profits Per Employee | 262,291 |
| Employee Count | 4,858 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.75% in the last 52 weeks. The beta is 0.31, so Beijing Tiantan Biological Products's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -8.75% |
| 50-Day Moving Average | 22.57 |
| 200-Day Moving Average | 23.52 |
| Relative Strength Index (RSI) | 53.39 |
| Average Volume (20 Days) | 23,370,438 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beijing Tiantan Biological Products had revenue of CNY 5.23 billion and earned 1.27 billion in profits. Earnings per share was 0.64.
| Revenue | 5.23B |
| Gross Profit | 2.89B |
| Operating Income | 1.99B |
| Pretax Income | 2.08B |
| Net Income | 1.27B |
| EBITDA | 2.30B |
| EBIT | 1.99B |
| Earnings Per Share (EPS) | 0.64 |
Balance Sheet
The company has 4.80 billion in cash and 39.25 million in debt, giving a net cash position of 4.77 billion or 2.41 per share.
| Cash & Cash Equivalents | 4.80B |
| Total Debt | 39.25M |
| Net Cash | 4.77B |
| Net Cash Per Share | 2.41 |
| Equity (Book Value) | 13.85B |
| Book Value Per Share | 5.38 |
| Working Capital | 6.99B |
Cash Flow
In the last 12 months, operating cash flow was 1.35 billion and capital expenditures -1.08 billion, giving a free cash flow of 269.83 million.
| Operating Cash Flow | 1.35B |
| Capital Expenditures | -1.08B |
| Free Cash Flow | 269.83M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 55.17%, with operating and profit margins of 38.06% and 24.36%.
| Gross Margin | 55.17% |
| Operating Margin | 38.06% |
| Pretax Margin | 39.79% |
| Profit Margin | 24.36% |
| EBITDA Margin | 43.99% |
| EBIT Margin | 38.06% |
| FCF Margin | 5.16% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | 259.97% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 19.50% |
| Buyback Yield | -1.32% |
| Shareholder Yield | -0.77% |
| Earnings Yield | 2.82% |
| FCF Yield | 0.60% |
Stock Splits
The last stock split was on June 20, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 20, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Beijing Tiantan Biological Products has an Altman Z-Score of 18.54.
| Altman Z-Score | 18.54 |
| Piotroski F-Score | n/a |